MicrosoftTeams-image (5).png
Lyophilized Injectable Market Primed to Surpass USD 5 Billion by 2031, According to Transparency Market Research
June 05, 2023 06:30 ET | Transparency Market Research
Wilmington, Delaware, United States, June 05, 2023 (GLOBE NEWSWIRE) -- The global lyophilized injectable market is projected to exceed value of US$ 5 Bn by 2031. It is expected to expand at a CAGR...
selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis
May 30, 2023 04:00 ET | AKAMPION
Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected for late...
ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002
May 24, 2023 04:00 ET | AKAMPION
- First-in-class checkpoint inhibitor IOS-1002 (targeting LILRB1 (ILT2), LILRB2 (ILT4), KIR3DL1) being evaluated as mono and combination therapy in patients with advanced solid tumors Schlieren...
Vantage Market Research.png
Monoclonal Antibodies Market Size & Share to Surpass $155.2 Billion by 2028 | Vantage Market Research
April 10, 2023 05:10 ET | Vantage Market Research
WASHINGTON, April 10, 2023 (GLOBE NEWSWIRE) -- The Global Monoclonal Antibodies Market is valued at USD 111.93 Billion in 2022 and is projected to reach a value of USD 186.67 Billion by 2030 at a...
BiondVax LOGO.png
BiondVax to Present at BIO-Europe Spring
March 16, 2023 13:10 ET | BiondVax Pharmaceuticals Ltd.
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing...
Biosimilars Market Size Worth ($136+ Billion by 2028) Lead by Intravenous Segment (36% CAGR) - Exclusive Research Study by The Insight Partners
February 27, 2023 07:39 ET | The Insight Partners
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biosimilars Market Size, Share, Growth, Strategy & Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
Featured Image for BioMed X Institute
BioMed X Launches New T Cell Immunology Discovery Platform
February 14, 2023 06:00 ET | BioMed X Institute (990552)
HEIDELBERG, Germany, Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioMed X announced today the launch of its new immunology discovery platform that will allow for the accurate and fast identification of target...
Injection Pen Market Size to Outstrip $60.33 Bn, Globally, by 2028 Growth Projections at 7.14% CAGR – Comprehensive Study by The Insight Partners
February 08, 2023 09:59 ET | The Insight Partners
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Injection Pen Market Size, Share, Growth and Global Forecast to 2028 - Global Analysis by Type (Disposable Injection...
ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002
January 17, 2023 04:00 ET | AKAMPION
- Lead compound IOS-1002 to be studied as mono and combination therapy in patients with advanced solid tumors- First patients to be enrolled in Q1, 2023 Schlieren (Zurich Area), Switzerland –...
BioMed X Logo
BioMed X and AbbVie Extend Research Collaboration in the US
January 16, 2023 13:00 ET | BioMed X Institute
HEIDELBERG, Germany, Jan. 16, 2023 (GLOBE NEWSWIRE) -- BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie....